Lawmakers grill U.S. FDA on response to Abbott baby formula safety
Reuters
5/25/2022
© Reuters/BRIAN SNYDER
FILE PHOTO: U.S. shortage of infant formula continues in Medford
By Ahmed Aboulenein and Manas Mishra
WASHINGTON (Reuters) -Lawmakers grilled U.S. Food and Drug Administration officials on Wednesday over what they saw as a lack of urgency in the agency's response to complaints about possible baby formula contamination at a now shuttered Abbott Laboratories plant that led to severe nationwide shortages.
© Reuters/KAYLEE GREENLEE BEAL
FILE PHOTO: Empty shelves show a shortage of baby formula in San Antonio
FDA leaders appeared before a congressional panel to answer questions about the crisis after Abbott in February recalled some products and closed its manufacturing plant in Sturgis, Michigan.
"There are also questions surrounding the timeline of FDA's investigation and response," said Representative Diana DeGette, chairwoman of the U.S. House of Representatives Commerce and Energy Subcommittee on Oversight and Investigations.
The Democrat cited "a four-month lapse before returning to inspect the Sturgis facility," and a delay in contacting a former Abbott employee whistleblower.
Senior leaders like then-acting Commissioner Janet Woodcock and Deputy Commissioner for Food Policy and Response Frank Yiannas only saw the complaint in February because of pandemic-related mail routing issues, FDA officials said.
"FDA's timeliness of interviewing the whistleblower and getting into the facility for a for-cause inspection were too slow and some decisions could have been more optimal," acknowledged FDA Commissioner Robert Califf.
Video: Baby formula shortage underscores the extent of Biden's incompetence: Hilton (FOX News)
-
Role of armed policing reconsidered after violently deadly traffic stop
MSNBC -
Parade shooting suspect charged with murder
MSNBC -
Covid-19 exposes North Korea's vulnerable health care system
CNN -
Euro 2022: England 'aware of expectation' says captain Williamson
AFP -
'It was carnage': Doctor describes damage by assault weapon to Highland Park gun victims
MSNBC -
'We'll get to the truth': Uvalde mayor fears cover-up of shooting investigation
CNN -
'It's a crime': Claire McCaskill on why DOJ should charge Trump
MSNBC -
'We are making progress': Democratic states passing new gun laws
MSNBC -
New study suggests nationwide abortion ban could lead to more maternal deaths
NBC News -
Nobilo: Key resignations deal blow to Boris Johnson
CNN -
Highland Park Suspect Is Charged With Seven Counts of Murder
The Wall Street Journal. -
Father describes horror, terror as family fled Highland Park shooting
MSNBC -
Remembering the lives of the victims of the Independence Day shooting
CNN -
Freeing WNBA's Griner from Russia a 'priority': White House
Reuters -
Highland Park shooting suspect left online trail of violent imagery
NBC News -
Highland Park community grieves July Fourth tragedy
NBC News
-
Role of armed policing reconsidered after violently deadly traffic stop Phillip Atiba Goff, co-founder and CEO of the Center for Policing Equity, talks about police in Akron, Ohio firing 90 bullets at a single Black man, hitting him 60 times, and how local police forces are reconsidering the circumstances in which armed officers are deployed.
MSNBC
-
Parade shooting suspect charged with murder The Highland Park parade shooting suspect faces seven first-degree murder charges, with the possibility of dozens of additional charges. It comes after a gunman fired over 70 rounds into a crowd at a July 4th parade outside of Chicago. Seven people were killed and more than 30 others were hurt. Meantime, the Jan. 6th committee announces its next public hearing. And a Georgia grand jury subpoenas Sen. Graham, Rudy Giuliani and Trump’s legal team in an election probe.
-
Covid-19 exposes North Korea's vulnerable health care system When North Korea admitted to a Covid-19 outbreak two months ago, the world feared catastrophic consequences, but we still don't know how bad the situation is. CNN's Paula Hancocks speaks to doctors who worked in the country and defectors who shed light on the health system.
CNN
"To my knowledge, there's no malfeasance there. These are people who are working very hard, but we had systems that were failing and decisions that could have been better."
The FDA inspected the plant following reports of bacterial infections in babies potentially linked to Abbott's formula, and the whistleblower complaint in late October.
A COVID outbreak at the plant delayed the inspection until Jan. 31. A second baby's death potentially linked to the plant was reported just after the factory was shuttered in February.
"Frankly, the inspection results were shocking," Califf said, noting that inspectors found cracks in vital equipment, a lack of adequate hand washing, evidence of previous bacterial contamination, and water leaks in areas were formula is produced, a risk factor for bacteria.
The plant is one of three run by Abbott, which has the largest U.S. market share for infant formula, and the company did not have a contingency plan to produce its specialty formulas that serve as the only source of nutrition for thousands of babies with metabolic disorders, the FDA said.
Califf said the best option was to enter into a consent decree agreement with Abbott, "where we literally have oversight of every single step" of remediation of problems at the facility to get it back on line as soon as possible.
Abbott plans to reopen the plant on June 4.
Abbott controlled 40% of the market before the plant closed, Christopher Calamari, president of Abbott U.S. nutrition, told lawmakers, and the plant accounts for 40% of Abbott's product.
Reckitt Benckriser had a 34% market share that grew to 56% since the closure, vice president for nutrition Robert Cleveland told lawmakers. Nestle saw its 8% share grow to 9%, Gerber vice president Scott Fitz said.
(Reporting by Ahmed Aboulenein in Washington and Manas Mishra in Bengaluru; Editing by Bill Berkrot)
Reuters
